St. Jude Medical (STJ) has risen sharply, recording gains of 5.3% in the past 4 weeks. However, the stock has corrected -0.11% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 0.89% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week. The stock has recorded a 20-day Moving Average of 2.87% and the 50-Day Moving Average is 4.24%.
St. Jude Medical (NYSE:STJ): The stock opened at $80.94 on Friday but the bulls could not build on the opening and the stock topped out at $80.94 for the day. The stock traded down to $80.40 during the day, due to lack of any buying support eventually closed down at $80.49 with a loss of -0.30% for the day. The stock had closed at $80.73 on the previous day. The total traded volume was 2,285,926 shares.
The company Insiders own 4.8% of St. Jude Medical shares according to the proxy statements. Institutional Investors own 85.55% of St. Jude Medical shares. In a related news, The officer (VP, Global Quality), of St Jude Medical Inc, Fecho Jeff had unloaded 10,408 shares at $51.71 per share in a transaction on February 5, 2016. The total value of transaction was $538,198. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker systems, atrial fibrillation (AF) products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring device and other vascular accessories), structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).